Intelligence / Healthtech / PMA Approvals / Medtronic, INC.
Approvalsdevice change approved (PMA)26 Aug 2026
Medtronic, INC.
26 Aug 2026: Device change approved (PMA) · INFUSE BONE GRAFT. Recorded in the openFDA device PMA data.
- Decided
- 26 Aug 2026
- Device
- INFUSE BONE GRAFT
- Specialty
- Dental
- Type
- Supplement (Normal 180 Day Track)
- Reason
- Change Design/Components/Specifications/Material
- Reference
- P050053 S066
- Location
- Memphis, TN
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Medtronic, INC.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Medtronic, INC. in our registers.
29 OctMedtronic, Inc.device cleared · HealthtechApprovals23 OctMedtronicdevice cleared · HealthtechApprovals17 SeptMedtronic, Inc.device cleared · HealthtechApprovals28 AugMedtronic, Inc.device cleared · HealthtechApprovals21 AugMedtronic, Inc.device cleared · HealthtechApprovals17 NovMedtronic Limitedwon a public contract (£272K) · HealthtechProcurement27 OctMedtronic, INC.device change approved (PMA) · HealthtechApprovals23 SeptMedtronicdevice change approved (PMA) · HealthtechApprovals10 SeptMedtronic, INC.device change approved (PMA) · HealthtechApprovals4 NovMedtronic, INC.Class II recall · HealthtechQuality4 NovMedtronic, INC.Class II recall · HealthtechQuality4 NovMedtronic, INC.Class II recall · HealthtechQuality
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.